Insulet Investors
The OmniPod Insulin Management System is a product developed, manufactured, and sold by Insulet Corporation.
Founded Date:
2000
Total Funding:
129500000
Employee Number:
1001-5000
Funding Status:
IPO
Last Funding Type:
Post-IPO Debt
Acquisitions Number:
1
Investors Number:
12
Last Funding Date:
2009-03-16 00:00:00
Industry:
Biotechnology, Health Care, Medical Device
Headquarters:
Bedford, Massachusetts, United States
Estimated Revenue:
$100M to $500M